BETA DIAGNOSTIC LABS LLC NPI 1457003329

NPI Information

  • NPI: 1457003329
  • Provider Name: BETA DIAGNOSTIC LABS LLC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • Address: 7200 WASHINGTON AVE STE 104
    MT PLEASANT, WI
    ZIP 53406
  • Phone: (262) 583-0068

Map and Directions

Get Directions

NPI Details

BETA DIAGNOSTIC LABS LLC is a clinical medical laboratory in Mt Pleasant, WI. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. BETA DIAGNOSTIC LABS LLC NPI is 1457003329. The provider is registered as an organization entity type.

The provider's business location address is:

7200 WASHINGTON AVE STE 104
MT PLEASANT, WI
ZIP 53406-516
Phone: (262) 583-0068
Fax: (262) 583-0079

The provider's authorized official is Tom C Tousis .
The authorized official title is Owner and has the following contact phone number (262) 583-0068.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
  • Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
  • Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
  • Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
  • Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
  • 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
  • Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Bacterial colony count, urine (HCPCS:87086)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)

The enumeration date for this NPI number is 1/21/2022 and was last updated on 8/8/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1291U00000XClinical Medical LaboratoryYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.